NewsDaily: FDA panel rejects Avastin for breast cancer use

30-06-2011_06:05
Health advisers delivered a blow to Roche Holding on Wednesday, voting to reject the use of Roche Holding drug Avastin for breast cancer while the Swiss drugmaker conducts more studies.
ReadMore